Stalder G, Suffiotti M, Segot A, Noto A, Pantaleo G, Spertini O, Obeid M. Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial. haematol [Internet]. 2023Jan.1 [cited 2024Apr.26];108(1):234-9. Available from: https://haematologica.org/article/view/haematol.2022.281221